Confidential Disclosure Agreement In Clinical Research Template for Saudi Arabia

1. Third Party Disclosure: Include when third parties (e.g., contract research organizations) may need access to confidential information

2. International Data Transfer: Include when confidential information may be transferred outside Saudi Arabia

3. Publication Rights: Include when parties need to establish rules for publishing research results

4. Intellectual Property Rights: Include when the shared information includes patentable inventions or other IP

5. Emergency Disclosure Provisions: Include when handling clinical trial data that might need emergency disclosure for patient safety

6. Data Protection Officer: Include when the scale of data processing requires formal oversight roles

7. Insurance and Indemnification: Include when specific risk allocation is needed beyond standard confidentiality obligations

1. Schedule 1: Description of Clinical Research Project: Detailed description of the research project and its objectives

2. Schedule 2: Categories of Confidential Information: Specific listing of types of confidential information to be shared

3. Schedule 3: Security Protocols: Detailed technical and procedural requirements for data security

4. Schedule 4: Authorized Personnel: List of individuals authorized to access confidential information

5. Schedule 5: Data Handling Procedures: Specific procedures for handling different types of clinical research data

6. Appendix A: SFDA Compliance Requirements: Specific requirements from SFDA regulations that must be followed

7. Appendix B: Form of Confidentiality Undertaking: Template for individual confidentiality undertakings by team members